BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10929770)

  • 1. Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
    Kusakabe H; Iwasaki H; Sano K; Kiyokane K
    Arch Dermatol Res; 2000 Jun; 292(6):292-300. PubMed ID: 10929770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
    Uchiyama-Kokubu N; Watanabe T
    Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution.
    Cheng SH; Lam W; Lee AS; Fung KP; Wu RS; Fong WF
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):134-42. PubMed ID: 10764626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
    Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
    Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.
    Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M
    Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
    Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
    J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma.
    Schwarzenbach H
    Med Oncol; 2002; 19(2):87-104. PubMed ID: 12180485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
    Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
    Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
    Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
    Labialle S; Dayan G; Gambrelle J; Gayet L; Barakat S; Devouassoux-Shisheboran M; Bernaud J; Rigal D; Grange JD; Baggetto LG
    Melanoma Res; 2005 Aug; 15(4):257-66. PubMed ID: 16034303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line.
    Celestino AT; Levy D; Maria Ruiz JL; Bydlowski SP
    Biochem Biophys Res Commun; 2015 Feb; 457(4):664-8. PubMed ID: 25603048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
    Kitazono M; Okumura H; Ikeda R; Sumizawa T; Furukawa T; Nagayama S; Seto K; Aikou T; Akiyama S
    Int J Cancer; 2001 Jan; 91(1):126-31. PubMed ID: 11149411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
    Berger W; Elbling L; Micksche M
    Int J Cancer; 2000 Oct; 88(2):293-300. PubMed ID: 11004683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of in vivo adriamycin-induced multidrug resistance models of subcutaneous and hepatic transplanted human liver cancer in nude mice].
    Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
    Ai Zheng; 2004 Aug; 23(8):905-9. PubMed ID: 15301712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.